Accelerate Diagnostics
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $2,816 | $2,975 | $2,986 | $2,921 |
Gross Profit | 449 | 856 | 676 | 723 |
EBITDA | -34,698 | -10,168 | -8,122 | -10,922 |
EBIT | -32,085 | -11,046 | -8,999 | -11,780 |
Net Income | -9,588 | -14,639 | -11,588 | -14,230 |
Net Change In Cash | 2,816 | 2,975 | 2,986 | 2,921 |
Free Cash Flow | -5,068 | -3,085 | -7,585 | -8,965 |
Cash | 15,098 | 19,691 | 8,588 | 14,606 |
Basic Shares | 23,302 | 24,915 | 23,058 | 19,216 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $11,698 | $12,059 | $12,752 | $11,782 |
Gross Profit | 2,704 | 2,550 | 3,303 | -381 |
EBITDA | -35,310 | -49,771 | -55,799 | -59,594 |
EBIT | -53,025 | -58,799 | -62,112 | |
Net Income | -50,045 | -61,618 | -62,493 | -77,702 |
Net Change In Cash | 11,698 | 12,059 | 12,752 | 11,782 |
Cost of Revenue | 4,117 | |||
Free Cash Flow | -24,194 | -41,230 | -49,282 | -47,926 |
Cash | 15,098 | 12,138 | 34,905 | 39,898 |
Basic Shares | 23,302 | 12,477 | 6,172 | 6,172 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$0.37 |
2024-09-30 | -$0.59 |
2024-06-30 | -$0.53 |
2024-03-31 | -$0.88 |
